Literature DB >> 21287168

Iterative reconstruction or filtered backprojection for semi-quantitative assessment of dopamine D₂ receptor SPECT studies?

Walter Koch1, Christine Suessmair, Klaus Tatsch, Gabriele Pöpperl.   

Abstract

PURPOSE: In routine clinical practice striatal dopamine D(2) receptor binding is generally assessed using data reconstructed by filtered backprojection (FBP). The aim of this study was to investigate the use of an iterative reconstruction algorithm (ordered subset expectation maximization, OSEM) and to assess whether it may provide comparable or even better results than those obtained by standard FBP.
METHODS: In 56 patients with parkinsonian syndromes, single photon emission computed tomography (SPECT) scans were acquired 2 h after i.v. application of 185 MBq [(123)I]iodobenzamide (IBZM) using a triple-head gamma camera (Siemens MS 3). The scans were reconstructed both by FBP and OSEM (3 iterations, 8 subsets) and filtered using a Butterworth filter. After attenuation correction the studies were automatically fitted to a mean template with a corresponding 3-D volume of interest (VOI) map covering striatum (S), caudate (C), putamen (P) and several reference VOIs using BRASS software.
RESULTS: Visual assessment of the fitted studies suggests a better separation between C and P in studies reconstructed by OSEM than FBP. Unspecific background activity appears more homogeneous after iterative reconstruction. The correlation shows a good accordance of dopamine receptor binding using FBP and OSEM (intra-class correlation coefficients S: 0.87; C: 0.88; P: 0.84). Receiver-operating characteristic (ROC) analyses show comparable diagnostic power of OSEM and FBP in the differentiation between idiopathic parkinsonian syndrome (IPS) and non-IPS.
CONCLUSION: Iterative reconstruction of IBZM SPECT studies for assessment of the D(2) receptors is feasible in routine clinical practice. Close correlations between FBP and OSEM data suggest that iteratively reconstructed IBZM studies allow reliable quantification of dopamine receptor binding even though a gain in diagnostic power could not be demonstrated.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21287168     DOI: 10.1007/s00259-011-1737-9

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  33 in total

1.  Quantitation of neuroreceptors: a need for better SPECT imaging.

Authors:  T Kauppinen; J Yang; H Kilpeläinen; J T Kuikka
Journal:  Nuklearmedizin       Date:  2001-08       Impact factor: 1.379

2.  Can SPET imaging of dopamine uptake sites replace PET imaging in Parkinson's disease? For.

Authors:  Klaus Tatsch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-03-23       Impact factor: 9.236

3.  European Association of Nuclear Medicine procedure guidelines for brain neurotransmission SPET using (123)I-labelled dopamine D(2) transporter ligands.

Authors:  K Tatsch; S Asenbaum; P Bartenstein; A Catafau; C Halldin; L S Pilowsky; A Pupi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-10       Impact factor: 9.236

4.  Iterative methods for the three-dimensional reconstruction of an object from projections.

Authors:  P Gilbert
Journal:  J Theor Biol       Date:  1972-07       Impact factor: 2.691

5.  Algebraic reconstruction techniques (ART) for three-dimensional electron microscopy and x-ray photography.

Authors:  R Gordon; R Bender; G T Herman
Journal:  J Theor Biol       Date:  1970-12       Impact factor: 2.691

6.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

7.  Evaluation of linear registration algorithms for brain SPECT and the errors due to hypoperfusion lesions.

Authors:  P E Radau; P J Slomka; P Julin; L Svensson; L O Wahlund
Journal:  Med Phys       Date:  2001-08       Impact factor: 4.071

8.  Iterative reconstruction with correction of the spatially variant fan-beam collimator response in neurotransmission SPET imaging.

Authors:  Deborah Pareto; Albert Cot; Javier Pavía; Carles Falcón; Ignacio Juvells; Francisco Lomeña; Domènec Ros
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-07-03       Impact factor: 9.236

9.  [Study of the pre and post-synaptic dopaminergic system by DaTSCAN/IBZM SPECT in the differential diagnosis of parkinsonism in 75 patients].

Authors:  J Vaamonde; R Ibáñez; A M García; V Poblete
Journal:  Neurologia       Date:  2004 Jul-Aug       Impact factor: 3.109

10.  Test-retest variability and reliability of 123I-IBZM SPECT measurement of striatal dopamine D2 receptor availability in healthy volunteers and influence of iterative reconstruction algorithms.

Authors:  Ana M Catafau; Santiago Bullich; Mónica Danús; María M Penengo; Albert Cot; Sergio Abanades; Magí Farré; Javier Pavía; Domènec Ros
Journal:  Synapse       Date:  2008-01       Impact factor: 2.562

View more
  3 in total

1.  Cross-camera comparison of SPECT measurements of a 3-D anthropomorphic basal ganglia phantom.

Authors:  Walter Koch; Perry E Radau; Wolfgang Münzing; Klaus Tatsch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-01-25       Impact factor: 9.236

2.  European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis.

Authors:  Andrea Varrone; John C Dickson; Livia Tossici-Bolt; Terez Sera; Susanne Asenbaum; Jan Booij; Ozlem L Kapucu; Andreas Kluge; Gitte M Knudsen; Pierre Malick Koulibaly; Flavio Nobili; Marco Pagani; Osama Sabri; Thierry Vander Borght; Koen Van Laere; Klaus Tatsch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-11-16       Impact factor: 9.236

3.  Multimodal molecular 3D imaging for the tumoral volumetric distribution assessment of folate-based biosensors.

Authors:  Gerardo J Ramírez-Nava; Clara L Santos-Cuevas; Isaac Chairez; Liliana Aranda-Lara
Journal:  Med Biol Eng Comput       Date:  2017-12-01       Impact factor: 2.602

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.